SignatureFD’s Cullinan Oncology CGEM Stock Holding History

SignatureFD’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$49.2K	Hold	3,207	–	–	﹤0.01%	1965
2026 Q2	$58.4K	Sell	3,207 -2,343	-42%	-$34.8K	﹤0.01%	1775
2026 Q1	$78.9K	Buy	5,550 +1,420	+34%	+$18.2K	﹤0.01%	1467
2025 Q4	$42.7K	Buy	4,130 +3,607	+690%	+$32.5K	﹤0.01%	1745
2025 Q3	$3.1K	Buy	523 +134	+34%	+$981	﹤0.01%	2822
2025 Q2	$2.93K	Buy	389 +157	+68%	+$1.26K	﹤0.01%	2763
2025 Q1	$1.76K	Sell	232 -219	-49%	-$2.1K	﹤0.01%	2909
2024 Q4	$5.49K	Hold	451	–	–	﹤0.01%	2572
2024 Q3	$7.55K	Hold	451	–	–	﹤0.01%	2447
2024 Q2	$7.86K	Hold	451	–	–	﹤0.01%	2367
2024 Q1	$7.68K	Sell	451 -407	-47%	-$6.29K	﹤0.01%	2404
2023 Q4	$8.74K	Buy	858 +254	+42%	+$2.25K	﹤0.01%	2320
2023 Q3	$5.47K	Buy	+604	New	+$6.29K	﹤0.01%	2457
2023 Q2	–	Sell	-171	Closed	-$1.75K	–	3256
2023 Q1	$1.75K	Buy	+171	New	+$1.88K	﹤0.01%	2839
2022 Q4	–	Sell	-64	Closed	-$1K	–	3304
2022 Q3	$1K	Buy	64 +24	+60%	+$323	﹤0.01%	2926
2022 Q2	$1K	Buy	+40	New	+$454	﹤0.01%	2884
2021 Q3	–	Sell	-29	Closed	-$1K	–	3058
2021 Q2	$1K	Buy	+29	New	+$892	﹤0.01%	2696

Other funds holding CGEM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $620M AUM 38.17% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

SignatureFD's CGEM Position: Q3 2026 in Review

SignatureFD held its Cullinan Oncology (CGEM) position steady in Q3 2026 at 3,207 shares worth $49.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1965.

SignatureFD first reported a position in CGEM in Q2 2021 and has held it in 17 quarters since. The position peaked at $78.9K in Q1 2026. 55 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.

SignatureFD held 3,207 shares of Cullinan Oncology worth $49.2K as of Q3 2026.
SignatureFD left its Cullinan Oncology share count unchanged in Q3 2026.
Cullinan Oncology made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1965 holding.
SignatureFD first reported a position in Cullinan Oncology in Q2 2021 and has held it in 17 quarters since.
SignatureFD's Cullinan Oncology position peaked at $78.9K in Q1 2026.
55 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.